Sevelamer in Proteinuric CKD

NCT01968759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Sevelamer
DRUG: Ramipril and Irbesartan

Sponsor

Mario Negri Institute for Pharmacological Research